CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising geriatric population and subsequent growth in the prevalence of heart valve diseases
4.1.2. Increasing government funding for heart valve research
4.1.3. Novel technological advancements in prosthetic heart valves
4.1.4. The rise in number of trans catheter heart valve surgery centres
4.2. Market Restraints & Challenges
4.2.1. High cost and risk associated with prosthetic heart valves
4.2.2. The stringent approval process for prosthetic heart valves & unfavourable reimbursement scenario
4.2.3. Availability of alternative methods for treating heart valve diseases
4.3. Market Opportunities
4.3.1. Strong growth potential in emerging countries
4.3.2. Robust production pipeline with growing investments by key players
CHAPTER 5 GLOBAL PROSTHETIC HEART VALVE MARKET – BY TYPE
5.1. Mechanical Heart Valve
5.2. Tissue Heart Valve
5.3. Stented Tissue Heart Valve
5.4. Stentless Tissue Heart Valve
5.5. Trans catheter Heart Valve
CHAPTER 6 GLOBAL PROSTHETIC HEART VALVE MARKET – BY END USER
6.1. Hospitals & Clinics
6.2. Ambulatory Surgical Centers
6.3. Research Laboratories
CHAPTER 7 GLOBAL PROSTHETIC HEART VALVE MARKET - BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.8. Switzerland
7.4.9. Poland
7.4.10. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8 GLOBAL PROSTHETIC HEART VALVE MARKET - COMPANY PROFILES
8.1. Neovasc, Inc.
8.2. Medtronic PLC
8.3. Edwards Lifesciences Corporation
8.4. Boston Scientific Corporation
8.5. Livanova PLC
8.6. St. Jude Medical, Inc.
8.7. Symetis SA
8.8. Jenavalve Technology, Inc.
8.9. Cryolife, Inc.
8.10. TTK Healthcare Limited (A TTK Group Company)
8.11. Colibri Heart Valve, LLC
8.12. Lepu Medical Technology Co., Ltd.
8.13. Braile Biomédica
8.14. Abbott Laboratories
CHAPTER 9 GLOBAL PROSTHETIC HEART VALVE MARKET - COMPETITIVE LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10 MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11 APPENDIX
11.1. List of Tables
11.2. List of Figures
